Displaying 1 - 1 of 1
| Active Ingredient | VALACYCLOVIR |
| Therapeutic Class | NUCLEOSIDES AND NUCLEOTIDES |
| Indications | .Effective in treating initial or recurrent herpes simplex virus, herpes zoster and varicella zoster virus infections |
| Caution |
Valacyclovir is generally well tolerated. GI disturbances, nausea, abdominal pain, renal failure, local reactions at the injection site, headache and rash may occur. A finger cot or rubber glove sho More ... |
| Dose Range | Herpes zoster: 1g 3 times daily for 7 day s; Herp es simp lex: 500 mg twice daily for 3 to 5 day s for recurrent ep isodes or for up to 10 day s for a first ep isode. Treatment should be started as soon as sy mp toms occur; ideally within 48 to 72 hours. |
| Drug Interactions | |
| Pregnancy | Not known to be harmful—manufacturers advise use only when potential benefit out More ... |
| Breast Feeding | Significant amount in milk after systemic administration—not known to be harmful More ... |